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Mast cells play important roles in both innate 
and adaptive immune responses. They are cen-
tral eff  ector cells in immune responses to para-
sites and in the pathogenesis of diseases such as 
asthma and allergy (1, 2). The high affi   nity re-
ceptor for IgE (FcεRI) is one of several cell sur-
face receptors critical for mast cell development 
and function (3). FcεRI binds to IgE in the ab-
sence of antigen and subsequent cross-linking of 
IgE-bound FcεRI by cognate antigen induces a 
signaling cascade that leads to mast cell degranu-
lation and cytokine secretion, which contribute 
to both chronic allergic infl  ammation and acute 
anaphylaxis. Understanding FcεRI signaling 
and mast cell activation is critical to devising 
new therapies for mast cell–mediated diseases.
Recent studies have greatly improved our 
understanding of FcεRI signaling. After FcεRI 
engagement, the Src family members Lyn and 
Fyn and the tyrosine kinase Syk are activated 
(4, 5). These molecules in turn recruit and ac-
tivate other kinases such as the Tec family ki-
nase Btk (6), phospholipid modifying enzymes 
including phosphatidylinositol 4,5-bisphos-
phate 3-kinase (PI3K) (7), the GTPase-activat-
ing molecule Vav1 (8), and adaptor molecules 
such as linker for activated T cells (LAT) (9), non–
T cell activation linker (NTAL/LAB) (10, 11), 
SH2 domain containing leukocyte phospho-
protein of 76 kD (SLP-76) (12, 13), and Grb2-
associated binder protein 2 (Gab2) (14). The 
formation of a multimolecular signaling com-
plex coordinates activation of various down-
stream signaling pathways necessary for mast 
cell eff  ector functions. These pathways include 
phospholipase Cγ (PLCγ) (15, 16), protein 
  kinase C (PKC) isoforms (17, 18), and mito-
gen-activated protein kinases (MAPKs) (19). 
PLCγ hydrolyzes the membrane phospholipid 
  phosphatidylinositol 4,5-bisphosphate (PIP2), 
leading to the generation of two important 
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  second messengers, diacylglycerol (DAG) and inositol 1,4,5-
trisphosphate (IP3). IP3 binds to its receptor in the endoplas-
mic reticulum and induces Ca2+ release into the cytoplasm. 
DAG recruits to the membrane and activates PKC family 
members and RasGRPs, which are recently identifi  ed gua-
nine nucleotide exchange factors for Ras and Rap (20). Syn-
ergistic action of multiple downstream signals, particularly 
Ca2+ and PKCs, are required to induce mast cell degranula-
tion (18, 21, 22). Activated PKCs and MAPKs together pro-
mote transcription of many proinfl  ammatory genes, including 
cytokines (22–25).
Both in vitro and in vivo evidence suggest a critical role 
for DAG in the regulation of mast cell function after FcεRI 
engagement. Treatment of mast cells with DAG analogues in 
the presence of a Ca2+ ionophore can mimic FcεRI engage-
ment and induce mast cells to degranulate and release active 
mediators (26, 27). Mice lacking PLCγ2, the enzyme that 
generates IP3 and DAG, have diminished mast cell function 
(28, 29). Similarly, defi  ciency in DAG eff  ector molecules 
  alters mast cell function. Multiple PKCs are expressed in mast 
cells, and activation of both classical and novel isoforms of 
PKC is regulated by DAG (18, 30). Diff  erent PKCs have dis-
tinct functions in mast cells. PKCβ−/− mast cells demonstrate 
decreased IL-6 production and degranulation in response to 
FcεRI engagement (22), whereas PKCδ−/− mast cells re-
spond more vigorously to suboptimal FcεRI stimulation with 
more sustained Ca2+ mobilization and increased degranula-
tion compared with WT mast cells (31). Thus, proper bal-
ance of PKCβ and PKCδ activities appears important for 
mast cell function.
These observations suggest that DAG levels must be 
tightly controlled in mast cells. One mechanism for terminat-
ing DAG signaling is by phosphorylation catalyzed by the 
DAG kinase (DGK) family of enzymes. Phosphorylation of 
DAG by DGKs converts DAG to phosphatidic acid (PA), 
thus preventing DAG from activating PKCs and RasGRPs 
(20, 32–34). Additionally, PA itself is a second messenger, 
and DGK activity could regulate mast cell function by aff  ect-
ing PA accumulation. In vitro, PA is a potent activator of 
PLC and phosphatidylinositol 4-phosphate 5-kinase (PI5K), 
enzymes involved in PIP2 degradation and production (35–37). 
Therefore, through conversion of DAG into PA, DGK 
  enzymes could regulate many aspects of inositol lipid metab-
olism and mast cell activation after FcεRI engagement.
We recently described mice defi   cient in DGKζ and 
demonstrated that T cells from these animals are hyper-
  responsive to TCR stimulation. DGKζ−/− mice mount en-
hanced antiviral immune responses, indicating that DGKζ is 
an important in vivo negative regulator of TCR signaling 
and T cell activation (38, 39). We show here that DGKζ 
also regulates immune receptor signaling in mast cells. To 
our surprise, in vivo mast cell function is impaired in 
DGKζ−/− mice as indicated by diminished local anaphylac-
tic responses. To explore the mechanism underlying this 
fi  nding, we have studied DGKζ−/− bone marrow–derived 
mast cells (BMMCs). We demonstrate that FcεRI-induced 
degranulation of DGKζ−/− BMMCs is diminished, corre-
lating with impaired PLCγ activation and PKCβII mem-
brane translocation. Similar to what we have observed after 
TCR stimulation, however, FcεRI-induced activation of 
the Ras–Erk signaling pathway is enhanced and DGKζ−/− 
BMMCs produce increased IL-6 during IgE sensitization 
and after antigen cross-linking of the FcεRI. Moreover, 
mast cell survival after growth factor withdrawal is greatly 
increased by DGKζ defi  ciency, correlating with maintained 
phosphorylation of Akt. These fi  ndings indicate that DGKζ 
functions to maintain mast cell responsiveness to antigen 
stimulation during passive sensitization with IgE and dem-
onstrate separation of cytokine production and degranula-
tion after FcεRI stimulation of mast cells.
RESULTS
Mast cells develop in DGK𝗇-defi  cient mice
We previously reported that DGKζ plays an important role 
in T cell activation (38, 39). DGKζ is also expressed in mast 
cells and, as in T cells, the 115-kD isoform is prominent (Fig. 
1 A). There are also smaller species reactive with the anti-
DGKζ antibody, which may be products of protein degrada-
tion, as mast cells are rich in granules containing proteases. 
Alternatively, these might represent products of alternate 
transcripts. Importantly, the three major species reactive with 
the DGKζ antibody are all absent in BMMCs from targeted 
mice (Fig. 1 A). Mast cell development is unaff  ected  by 
DGKζ defi  ciency for the following reasons: the numbers of 
mast cells in ear, skin, stomach, and spleen are similar in WT 
and DGKζ−/− mice (Fig. 1 B and not depicted); electron 
microscopy did not reveal any diff  erences in cell morphol-
ogy or number of intracellular granules (not depicted); and 
KO mast cells express similar levels of c-Kit and FcεRI on 
their surfaces (Fig. 1 C). Additionally, DGKζ defi  ciency does 
not result in compensatory up-regulation of transcripts for 
related DGK isoforms (Fig. S1, available at http://www.jem.
org/cgi/content/full/jem.20052424/DC1).
Decreased passive cutaneous anaphylaxis 
in DGK𝗇-defi  cient mice
DGKζ−/− T cells have enhanced homeostatic proliferation 
and antiviral responses in vivo (39). To test the importance of 
DGKζ in mast cell function, we assessed allergic responses by 
examining passive cutaneous anaphylaxis (PCA), an in vivo 
measure of FcεRI-dependent mast cell function. Unexpect-
edly, DGKζ−/− mice had signifi  cantly impaired localized 
anaphylactic responses (Fig. 2 A).
To explore why DGKζ−/− mice demonstrate impaired 
PCA responses, we fi  rst compared FcεRI-triggered degranu-
lation in WT versus DGKζ−/− BMMCs by measuring 
β-hexosaminidase release (Fig. 2 B). FcεRI-induced degran-
ulation was signifi  cantly diminished in DGKζ−/− BMMCs 
(Fig. 2 B). PMA plus ionomycin (Io) stimulation, however, 
resulted in similar degranulation in WT and DGKζ−/− 
BMMCs, indicating that the ability to release granules 
and total granule content is unaff  ected by DGKζ defi  ciency. JEM VOL. 203, June 12, 2006  1473
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The impairment of FcεRI-induced mast cell degranula-
tion likely contributes to the decreased PCA responses in 
DGKζ−/− mice.
Another consequence of FcεRI engagement is the pro-
duction of proinfl  ammatory cytokines such as IL-6. IgE alone 
can induce a signifi  cant amount of IL-6 production in WT 
BMMCs (Fig. 2 C), which is consistent with previous reports 
(40). Cross-linking the receptor with antigen induces even 
more IL-6 production. Under both stimulation conditions, 
DGKζ−/− BMMCs produce approximately twofold more 
IL-6 than WT BMMCs. Therefore, DGKζ defi  ciency im-
pairs FcεRI-induced degranulation, but increases cytokine 
production after IgE sensitization and after cross-linking of 
the receptor with antigen.
Antigen stimulation of IgE-sensitized BMMCs
Cross-linking of IgE-bound FcεRI results in activation of 
a signaling network that coordinates mast cell eff  ector func-
tions. To investigate why DGKζ−/− BMMCs have impaired 
degranulation but enhanced cytokine production after FcεRI 
stimulation, we assessed how DGKζ defi  ciency aff  ects anti-
gen-induced FcεRI signaling in IgE-sensitized BMMCs. We 
fi  rst verifi  ed that DGKζ phosphorylates DAG after antigen 
stimulation of BMMCs by measuring PA production. Addi-
tion of DNP-HSA to IgE-sensitized WT BMMCs results in 
robust PA accumulation beginning 5–10 min after stimula-
tion (Fig. 3 A). As expected, antigen stimulation of DGKζ−/− 
BMMCs results in signifi  cantly less PA accumulation.
We next examined signaling pathways that have been 
implicated in cytokine production after FcεRI ligation. 
  Activation of the PI3K/Akt and Ras/Erk pathways is re-
quired for cytokine production (23, 25, 41). Low dose 
stimulation of IgE-sensitized WT BMMCs with DNP-
HSA weakly activates Akt, but stimulation of DGKζ−/− 
BMMCs results in signifi  cantly increased Akt activation 
Figure 1.  DGK𝗇 expression and surface expression of Fc𝗆RI and 
c-Kit in BMMCs from WT and DGK𝗇-defi  cient mice. (A) DGKζ protein 
in cell lysates made from WT and DGKζ-defi  cient BMMCs was detected 
by Western blot analysis using an antibody specifi  c for the carboxyl-
  terminus of DGKζ (reference 71). The arrow indicates the 115-kD ζ1 
  isoform. (B) Mast cell distribution in the skin. Mast cells in the skin (back) 
and ears were stained with toluidine blue and were counted under a light 
microscope. Data shown are the means ± standard error of the number 
of mast cells per high-power fi  eld (10 × 100). (C) FcεRI and c-Kit expres-
sion on BMMCs. For FcεRI expression, WT and DGKζ-defi  cient BMMCs 
were incubated with 1 μg/ml anti-DNP IgE for 4 h (solid line) and FcεRI 
expression was detected by staining with a FITC-labeled anti-IgE second-
ary antibody. Cells that had not been incubated with IgE serve as a control 
(dotted line). For c-Kit expression, WT and DGKζ-defi  cient BMMCs were 
either stained with a PE-labeled control antibody (dotted line) or a 
PE-labeled anti–c-Kit antibody (solid line).
Figure 2.  Decreased passive cutaneous anaphylaxis and Fc𝗆RI-
  induced degranulation but increased IL-6 production as the result 
of DGK𝗇 defi  ciency. (A) WT and DGKζ−/− mice were injected subcutane-
ously with 25 ng IgE in 25 μl PBS in the right ear and with 25 μl PBS in 
the left ear. 24 h later, DNP-HSA and Evans blue dye were injected intra-
venously into the mice. 30 min after injection, tissue from the ears was 
collected, Evans blue was extracted, and the intensity of the dye was 
  measured by absorption at 610 nm (OD610). Each data point is OD610 of 
IgE-injected ear minus the OD610 of PBS-injected ear from the same 
mouse. Data shown comprise three experiments. (B) Decreased FcεRI-
induced degranulation in DGKζ−/− BMMCs. IgE-sensitized WT and 
DGKζ−/− BMMCs were left unstimulated or were stimulated with various 
concentrations of DNP-HSA at 37°C for 60 min. Cells were spun, and 
β-hexosaminidase activities in supernatants as well as in whole cell 
lysates of unstimulated BMMCs were measured. Data were calculated as 
percentage of β-hexosaminidase   activity in the supernatant to the activity 
in the whole cell lysates of the same genotype. Means ± standard error 
of triplicates are shown. Data are   representative of three experiments. 
(C) Increased IL-6 production in DGKζ-defi  cient BMMCs. WT and DGKζ-
 defi  cient BMMCs were left   unstimulated, were stimulated with 1 μg/ml 
IgE overnight, or were sensitized with 1 μg/ml IgE for 4 h and cross-linked 
with 30 ng/ml DNP-HSA overnight. IL-6 in the culture medium was 
  measure by ELISA. Data shown are means ± standard error of triplicates 
normalized to PMA/Io control and are representative of three experiments.1474  REGULATION OF MAST CELL FUNCTION BY DGKζ | Olenchock et al.
(Fig. 3 B). FcεRI activation of Ras is believed to be the 
result of Grb2-SOS activation (42, 43), but recent reports 
suggest that DAG might contribute to Ras activation 
through allosteric activation of the Ras   guanine-nucleo-
tide exchange factor RasGRP4 (44–46). As shown in Fig. 
3 C, FcεRI-induced Ras activity is enhanced in DGKζ−/− 
BMMCs. Consistent with the increased Ras   activation, 
we observed enhanced and prolonged Mek1/2 and Erk1/2 
phosphorylation in DGKζ−/− BMMCs compared with 
WT BMMCs (Fig. 3 D). The eff  ect of DGKζ defi  ciency 
is selective, however, as FcεRI-induced activation of the 
MAPKs p38 and Jnk is similar in WT and DGKζ−/− 
BMMCs (unpublished data). These data demonstrate that 
DGKζ   defi   ciency enhances FcεRI-induced activation of 
Akt, Ras, and Erk1/2, likely contributing to enhanced 
  cytokine production.
Figure 3.  Antigen stimulation of IgE-sensitized BMMCs. (A) DGKζ 
defi  ciency impairs PA production by BMMCs after FcεRI stimulation. 
BMMCs were sensitized for 4 h with IgE, labeled with 32P-orthorphos-
phate, and either left unstimulated or stimulated with 10 ng/ml DNP-HSA 
for 10 min. Lipids were extracted, separated by TLC, and quantifi  ed using a 
phosphorimager. PA, the product of DAG phosphorylation, was identifi  ed 
by comigration with a standard. Data are presented as fold-induction 
calculated by cpm of stimulated cells divided by cpm of unstimulated 
cells. Means ± standard error of four experiments are shown; *, P < 0.05. 
(B–D) WT and DGKζ−/− BMMCs were sensitized with IgE for 4 h and left 
unstimulated (U) or were stimulated either with 4 ng/ml of DNP-HSA for 
different times or with 100 ng/ml PMA (P) for 5 min. (B) AKT phosphoryla-
tion was assessed by immunoblot analysis using an antibody specifi  c for 
phosphorylated Ser473 of Akt. Total Akt is shown as a loading control. 
(C) Active Ras in lysates was measured by affi  nity precipitation using GST-
Raf-RBD agarose beads followed by immunoblot analysis. (D) MEK1/2 and 
ERK1/2 activity was assessed by immunoblot analysis using phospho-
specifi  c antibodies. Total MEK1/2 and ERK1/2 serve as loading controls. 
(E) Membrane recruitment of PKCβII is diminished in DGKζ−/− BMMCs. 
IgE-sensitized BMMCs were left unstimulated (−) or were stimulated with 
50 ng/ml DNP-HSA (DNP) or PMA (P) for 10 min. Triton-soluble membrane 
fractions were prepared and membrane translocation of PKC isoforms was 
determined by Western blot using antibodies to PKCβII, PKCδ, and cal-
nexin (CNX) as a loading control. One representative blot is shown and 
data from fi  ve (PKCβII) or three (PKCδ) experiments were quantifi  ed and 
normalized to CNX; combined data are represented graphically.JEM VOL. 203, June 12, 2006  1475
ARTICLE
Activation of PKC family members by DAG and Ca2+ 
coordinates mast cell degranulation after FcεRI stimulation 
(22, 47). As expected, antigen cross-linking induces mem-
brane recruitment of PKCβII and PKCδ in WT BMMCs 
(Fig. 3 E). However, we fi  nd that membrane recruitment of 
PKCβII is clearly diminished in DGKζ−/− BMMCs, whereas 
PKCδ recruitment is preserved. Unstimulated IgE-sensitized 
DGKζ−/− BMMCs also demonstrate diminished levels of 
membrane-associated PKCβII but normal PKCδ levels. 
Moreover, treatment with the DAG analogue PMA, which 
is not a DGK substrate and should be unaff  ected by DGK 
defi  ciency, results in impaired movement of PKCβII to the 
membrane in DGKζ−/− BMMCs but normal movement of 
PKCδ (Fig. 3 E, representative blot and graphical summary 
of replicates). The block in PKCβII recruitment was not the 
result of diminished protein levels, however, as total levels of 
PKCβII and PKCδ in whole cell lysates were not decreased 
in DGKζ−/− BMMCs as compared with WT BMMCs 
(Fig. S2, available at http://www.jem.org/cgi/content/full/
jem.20052424/DC1). These data provide a likely mechanism 
for the impaired degranulation we observe in DGKζ−/− 
BMMCs, as FcεRI cross-linking results in less recruitment of 
a positive regulator (PKCβII) of mast cell degranulation, but 
appropriate recruitment of a negative regulator of mast cell 
degranulation (PKCδ). The data also suggest that DGKζ is 
essential for FcεRI activity in addition to its eff  ect on DAG 
levels, as PMA and PMA/Io (unpublished data) fail to restore 
PKCβII recruitment in DGKζ−/− BMMCs.
Calcium response and PLC𝗄 activity in DGK𝗇−/− BMMCs
The diminished membrane recruitment of the Ca2+-dependent 
PKCβII along with the preserved movement of the Ca2+-
independent PKCδ led us to question whether DGKζ 
  defi  ciency  aff  ects  FcεRI-induced Ca2+ fl  ux.  Compared 
with WT BMMCs, DGKζ−/− BMMCs have a signifi-
cantly   diminished Ca2+ response after FcεRI stimulation 
by antigen (Fig. 4 A). Consistent with the decreased Ca2+ 
response, phosphorylation of PLCγ1 and PLCγ2 after 
stimulation of the FcεRI was decreased in DGKζ−/− 
BMMCs (Fig. 4 B). As tyrosine phosphorylation of PLCγ 
does not always correlate with its enzymatic activity (48), 
we analyzed PLC activity by assessing metabolism of the 
Figure 4.  Decreased Ca2+ responses and PLC𝗄 activity in DGK𝗇−/− 
mast cells. WT and DGKζ−/− BMMCs were sensitized for 4 h with IgE in 
cytokine-free media. (A) Deceased Ca2+ fl  ux in DGKζ−/− mast cells after 
FcεRI stimulation. WT and DGKζ−/− BMMCs were loaded with Indo-1 and 
stimulated with 100 ng/ml DNP-HSA to induce Ca2+ responses. Ca2+ fl  ux 
was determined by fl  ow cytometry based on the change of FL5/FL4 ratio. 
Data shown are representative of four experiments. (B) Decreased PLCγ 
phosphorylation in DGKζ−/− BMMCs after FcεRI stimulation. BMMCs 
were stimulated with different concentrations of DNP-HSA for 2 min. 
PLCγ phosphorylation was determined by Western blot with anti–phospho-
PLCγ1 and anti–phospho-PLCγ2 antibodies. The blots were probed with 
an anti-actin antibody as a loading control. (C) Decreased PIP2 hydrolysis 
in DGKζ−/− BMMCs. Cells were labeled with 32P-orthophosphate and 
stimulated for the indicated amounts of time with 10 ng/ml DNP-HSA; 
lipids were analyzed as in Fig. 3. PIP2 was identifi  ed by comigration with a 
standard. Data are means ± standard error of four different experiments. 
*, P = 0.01, 0.5 min stimulation, WT vs. DGKζ KO. (D) Diminished IP3 
generation in DGKζ−/− BMMCs. Cells were left unstimulated or were 
stimulated with 10 ng/ml DNP-HSA for 20 s or 2 min and lysed using 
perchloric acid, and IP3 was measured.
Figure 5.  IgE stimulation in the absence of antigen cross-linking 
results in enhanced signaling in DGKζ−/− BMMCs. BMMCs were 
rested in media without cytokines for at least 4 h and rested for 1 h in 
Tyrode’s buffer before stimulation. (A) Impaired PA production in DGKζ−/− 
BMMCs. Cells were labeled with 32P-orthophosphate for 1 h and stimu-
lated with 1 μg/ml IgE for 30 min. Lipids were extracted and PA pro-
duction was quantifi  ed as in Fig. 3. Means ± standard error of fi  ve 
experiments are shown. *, P < 0.05. (B) Enhanced Ras/ERK activation in 
DGKζ−/− BMMCs. BMMCs were stimulated with 1 μg/ml IgE for various 
amounts of time or with 100 ng/ml PMA for 5 min. Active Ras and ERK1/2 
phosphorylation were assessed as in Fig. 3. For the Ras blot, a space is 
included before the PMA lanes to designate that these samples were run 
on a separate gel.1476  REGULATION OF MAST CELL FUNCTION BY DGKζ | Olenchock et al.
PLC substrate PIP2 and production of IP3. After receptor 
cross-linking in WT BMMCs, PIP2 levels quickly decrease 
(Fig. 4 C), and IP3 levels increase (Fig. 4 D) as a result of 
PLC activity. Upon stimulation of DGKζ−/− BMMCs, we 
do not observe a decrease but rather a slight increase in PIP2 
levels (Fig. 4 C), and IP3 generation is impaired (Fig. 4 D). 
These data provide compelling evidence that DGKζ defi  -
ciency impairs activation of PLCγ after antigen stimulation 
of IgE-sensitized mast cells.
IgE signaling and function in the absence of antigen
IgE sensitization of DGKζ−/− BMMCs leads to increased 
  cytokine production and impaired PKCβII recruitment to 
the membrane, so we therefore examined how IgE alone sig-
naling and function is altered in DGKζ defi  ciency. IgE bind-
ing to FcεRI induces a large increase in PA in WT BMMCs 
(Fig. 5 A). DGKζ−/− BMMCs, in contrast, have a signifi  cant 
impairment in PA accumulation during IgE sensitization. 
DAG-dependent signaling is also enhanced in DGKζ−/− 
BMMCs during IgE sensitization, as Ras and Erk1/2 activity 
is enhanced (Fig. 5 B).
IgE binding to the FcεRI signals mast cell survival 
through up-regulation of antiapoptotic proteins (40, 49–52), 
and ex vivo mast cell survival and expansion requires IL-3 
(53, 54). In the presence of IL-3, both WT and DGKζ−/− 
mast cells survive and expand similarly (unpublished data). 
When IL-3 is withdrawn, WT BMMCs undergo apoptosis 
as expected (Fig. 6 A). Surprisingly, DGKζ−/− BMMCs have 
greatly enhanced survival in the absence of IL-3. IgE  enhances 
survival in both WT and DGKζ−/− BMMCs, but because 
survival in the absence of cytokines is so much greater in the 
DGKζ−/− BMMCs, the IgE survival eff  ect is less marked 
(Fig. 6, A and B).
Akt regulates cell survival and is activated by IgE binding 
to FcεRI (40). Akt is phosphorylated in WT BMMCs grown 
in cytokine-replete media, and this activation decreases after 
withdrawal of cytokines (Fig. 6 C). DGKζ−/− BMMCs, in 
contrast, have enhanced Akt activity during growth in cyto-
kine-replete media and maintain Akt activity after cytokine 
removal (Fig. 6 C). As cytokines stimulate inositol metabo-
lism, including PIP2 hydrolysis by PLCγ and phosphoryla-
tion by PI3K (55, 56), it is likely that DGKζ regulates signals 
generated through cytokine receptors in addition to its role 
in FcεRI signaling. Future work will explore the biochemi-
cal basis of this observation.
D  I  S  C  U  S  S  I  O  N 
We have studied mice that lack a key enzyme involved in 
DAG metabolism, DGKζ, to address the consequences of 
dysregulated DAG accumulation after immune receptor sig-
naling. We demonstrated recently that DGKζ functions as a 
key negative regulator of TCR signaling and T cell activation 
(38, 39). We show here that DGKζ plays an important and 
unexpected role in regulating signal transduction from the 
FcεRI in mast cells. DGKζ−/− BMMCs manifest decreased 
PA production, enhanced activation of the Ras-Mek-Erk 
signaling pathway, increased Akt phosphorylation, prolonged 
survival after cytokine deprivation, and enhanced production 
of IL-6 as compared with WT BMMCs. Surprisingly, IgE-
mediated PCA responses are signifi   cantly decreased in 
DGKζ−/− mice, concordant with impairment of receptor-
induced PLCγ activity and degranulation in DGKζ−/− 
BMMCs. We demonstrate that signals generated by IgE in 
the absence of antigen cross-linking are enhanced in DGKζ−/− 
BMMCs. These data demonstrate that DGKζ is important 
for inactivation of DAG-mediated signaling pathways in mast 
cells and that DGKζ also plays a critical role in maintaining 
Figure 6.  Enhanced survival of DGK𝗇−/− BMMCs after IL-3 
  withdrawal. WT and DGKζ−/− BMMCs were cultured in media without 
cytokines in the presence of different concentrations of IgE for 48 or 110 h. 
Survival of BMMCs was determined by staining with FITC-annexin V and PI 
and analyzed by fl  ow cytometry. (A) Representative dot-plots. (B) Per-
centage of live cells (Annexin-V and PI negative) in a full time course and 
at a range of concentrations of IgE. Data shown are representative of 
three experiments. (C) Akt phosphorylation during growth in cyto  kine-
replete media (+IL3/SCF) and after 18 h cytokine withdrawal (18 h, no 
cytokines) was assessed by immunoblot analysis. One representative blot 
is shown and data from three independent experiments were quantifi  ed, 
normalized to PLCγ1 signal, and represented graphically for comparison. 
P-AKT signal in WT cells grown in cytokine-replete media was arbitrarily 
set to 1.JEM VOL. 203, June 12, 2006  1477
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FcεRI responsiveness to antigen cross-linking. In addition, 
we demonstrate a novel FcεRI signaling alteration in 
DGKζ−/− BMMCs, in that receptor engagement results in 
poor PLCγ activity and degranulation but augmented cyto-
kine production.
The observation that DGKζ defi   ciency impairs PLCγ 
function after FcεRI stimulation of mast cells was unex-
pected, as DGKζ was predicted to function downstream of 
PLCγ. It is possible that enhanced DAG-dependent signaling 
during IgE sensitization of DGKζ−/− BMMCs promotes 
feedback inhibition of PLCγ and Ca2+ responses upon anti-
gen cross-linking of the FcεRI. Short pretreatment of mast 
cells with phorbol esters results in feedback inhibition of 
PLCγ that is mediated by PKCα and PKCε (57–59). Pro-
longed administration of phorbol esters, in contrast, down-
regulates PKC isoforms and potentiates PLC activity upon 
antigen stimulation (59). We do not see changes in PKC pro-
tein levels in DGKζ−/− BMMCs, and we report impaired 
PLC activity. PKC feedback inhibition might be indirect as 
well, as PKCβ can induce serine-phosphorylation of Btk at 
an inhibitory site, dampening Btk activation in mast cells 
(60). Btk phosphorylates and activates PLCγ after FcεRI 
stimulation, so feedback inhibition of Btk could contribute to 
diminished PLCγ activity (61). Alternatively, enhanced Erk 
activation in DGKζ−/− BMMCs could inhibit PLCγ associa-
tion with LAT, as has been observed in T cells after TCR 
engagement (62). However, we have not observed an obvi-
ous decrease in PLCγ2-LAT association in DGKζ−/− 
BMMCs after antigen cross-linking of the FcεRI (unpub-
lished data).
Alternatively, diminished PLCγ activity and PKCβII 
membrane recruitment might be a direct consequence of 
DGKζ defi  ciency. Although DGK activity terminates DAG 
signaling, it also creates PA (32, 33, 63). PA is a potent 
  activator of PLCγ enzymatic activity in vitro (35). In 
  addition, a recent report suggests that DGKζ, through pro-
duction of PA, may increase intracellular PIP2 by activation 
of PI5K Iα (37). Thus, DGKζ defi  ciency could lead to de-
creased PI5K activity, diminishing levels of the PLC sub-
strate PIP2. Our PIP2 measurements did not reveal any 
diff  erences in 32P incorporation into PIP2 in IgE-sensitized 
BMMCs (unpublished data), but more direct measures of 
PIP2 mass should be performed to ensure that steady state 
  levels of 32P-labeled PIP2 refl  ect total mass. The importance of 
diminished PA production to the phenotype of DGKζ−/− 
BMMCs is particularly diffi     cult to assess, as alternative 
pathways to generate PA exist. These pathways include the 
hydrolysis of phosphatidylcholine mediated by phospholi-
pase D and the acylation of lyso-PA by lyso-PA acyltrans-
ferases (63). phospholipase D–derived PA has been reported 
to regulate diverse cellular processes, particularly in vesicle 
transportation and exocytosis (64, 65). It is possible that PA 
generated by DGKζ performs a similar function to promote 
mast cell degranulation.
It is intriguing that membrane recruitment of PKCβII 
is diminished in unstimulated IgE-sensitized DGKζ−/− 
BMMCs and that PKCβII recruitment is not restored with 
PMA treatment. PMA is a DAG analogue and is not subject 
to phosphorylation by DGK, so we predict that if DGKζ 
acts only by regulating DAG levels, PMA treatment should 
restore PKCβII membrane recruitment. It is possible that 
DGKζ has adaptor functions in addition to its role in lipid 
metabolism, perhaps by participating in a complex with 
PKCβII or Btk directly (37, 66). Future work will explore 
this interesting observation.
We have been unable to directly measure an FcεRI-
induced change in DAG mass in WT or DGKζ−/− mast cells 
using standard biochemical approaches (unpublished data). 
The likely explanation is that the receptor-induced pool of 
DAG is a small fraction of the total cellular pool because 
DAG is important for other aspects of cell biology. We are 
currently developing imaging approaches to measure DAG 
localization using a fl  uorescently labeled DAG probe (67). 
We also will develop HPLC/MS/MS techniques to quantify 
particular DAG subspecies, which may be more markedly 
regulated than total cellular DAG (68). These approaches will 
allow us to measure dynamic changes in DAG localization 
after FcεRI stimulation as well as assess in vivo substrate spec-
ifi  city of DGKζ.
The increased Akt phosphorylation in DGKζ−/− BMMCs 
stimulated through cytokine or FcεRs is intriguing. It is pos-
sible that increased Akt activity is a consequence of greater 
PIP3 production in DGKζ−/− BMMCs, and preliminary 
data support this hypothesis. Decreased PA production in 
DGKζ−/− BMMCs might increase PI3K activity, as PA has 
been reported to inhibit this enzyme in vitro (69). Also, per-
haps decreased PLCγ activity in DGKζ−/− BMMCs increases 
the local concentration of PIP2 available as substrate for PI3K 
(66). The interrelation among diff   erent PI metabolites is 
complex and understanding the exact lipid alterations will re-
quire further study.
Our current studies of DGKζ in mast cells reveal impor-
tant roles for this enzyme in regulating FcεRI signaling. 
DGKζ is not only essential for terminating DAG activity 
but also appears to be critical for maintaining optimal FcεRI 
responsiveness to antigen cross-linking. A more complete 
understanding of the importance of DGK activity to mast 
cell function requires analysis of other DGK family mem-
bers. Ongoing biochemical and genetic studies are address-
ing this question.
MATERIALS AND METHODS
DGK𝗇-defi  cient mice. DGKζ−/− mice have been described previously 
(39) and were housed in pathogen-free facilities at the University of Penn-
sylvania and Duke University. All experiments using animals were per-
formed in accordance with regulations of the Institutional Animal Care and 
Use Committee of the University of Pennsylvania and Duke University.
Microscopic analysis of mast cells. Skin samples from the back of the 
trunk and the ears were collected from killed WT and DGKζ−/− mice. 
  Tissues were fi  xed and mounted in paraffi   n according to standard histologi-
cal procedures. Paraffi   n sections were stained with toluidine blue and mast 
cells in tissues were evaluated by microscopy. In each tissue, mast cells were 
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BMMCs. BM cells from tibias and femurs from WT and DGKζ−/− mice 
were harvested and incubated with Isocove’s medium (Mediatech, Inc.) 
supplemented with 15% FBS (Hyclone), 100 U/ml penicillin G, 100 U/ml 
streptomycin, and 292 μg/ml of l-glutamine, 10 mM Hepes (pH 7.4), 
0.1 mM nonessential amino acid, 1 mM sodium pyruvate, and 50 μM 
2-mercaptoethanol (IMDM-15) with IL-3–conditioned medium for 2 wk 
and further expanded for an additional 2–8 wk with the supplement of SCF-
conditioned medium made from cell lines engineered to produce these 
  cytokines (70).
Flow cytometry. BMMCs were analyzed directly or after 4-h sensitization 
with 1 μg/ml IgE. Cells were stained with fl  uorescently labeled antibodies 
in 5% FBS in PBS and were analyzed on a FACSCaliber (Becton Dickinson) 
with CELLQuest software. Antibodies used were PE-conjugated c-Kit and 
FITC-conjugated anti-IgE (BD Biosciences). To measure cell survival after 
cytokine withdrawal, cells were stimulated in IMDM-15 without cytokine 
at a concentration of 106 cells/ml in a 96-well plate with diff  erent concen-
trations of anti-DNP–IgE (0, 0.04, 0.2, 1, or 5 μg/ml; Sigma-Aldrich). After 
48 or 110 h incubation, cells were stained with propidium iodide and an-
nexin V–FITC (BD Biosciences) and were analyzed by fl  ow cytometry.
Measurement of PA and PIP2. BMMCs were sensitized at 37°C for 4 h 
in 1 μg/ml IgE in IMDM-15 without IL-3 or SCF. Cells were harvested 
and rested in Tyrode’s buff  er (10 mM Hepes, pH 7.4, 130 mM NaCl, 1 mM 
MgCl2, 5 mM KCl, 1.4 mM CaCl2, 5.6 mM glucose, and 1 mg/ml bovine 
serum albumin) for 1 h at 37°C. 32P-phosphoric acid (MP Biomedicals) was 
added to a concentration of 0.25 mCi/ml. Cells were left unstimulated or 
were stimulated with 10 ng/ml DNP-HSA. Stimulation was terminated by 
addition of 0.1 volume of ice-cold 2 M HCl and transfer of cells to ice for 
10 min. Lipids were extracted with 3 ml of 2:1 methanol:chloroform and 
phases were separated by addition of 2 ml 1 N NaCl and 2 ml of chloroform. 
Lipid phase was washed 1× with 3 ml of upper phase buff  er (upper phase of 
10:10:9 chloroform:methanol:1 M NaCl), dried under nitrogen, and sepa-
rated by thin-layer chromatography using a basic solvent (9:7:2 chloroform: 
methanol: 4 M NH4OH). PA and PIP2 were identifi  ed by comigration with 
standards (Sigma-Aldrich) and quantifi  ed using a phosphorimager.
Measurement of IP3. IgE-sensitized BMMCs were rested for 1 h in 
  Tyrode’s buff  er, then left unstimulated or stimulated for 20 s or 2 min with 
10 ng/ml DNP-HSA. Stimulations were terminated by addition of 0.2 vol 
20% perchloric acid for 20 min on ice. Proteins were sedimented and super-
natants were neutralized to pH 7.5 by titration of 1.5 M KOH 60 mM 
Hepes containing universal indicator dye (Sigma-Aldrich). KClO4 was pre-
cipitated by centrifugation and IP3 was measured in supernatants by radio-
receptor   assay according to the manufacturer’s protocol (PerkinElmer).
Western blot analysis. For DGKζ expression, BMMCs were lysed in 1% 
NP-40 lysis buff  er (1% NP-40, 150 mM NaCl, 50 mM Tris, pH 7.4) with 
protease inhibitors. Proteins were resolved by SDS-PAGE, transferred to 
Trans-Blot Nitrocellulose membrane (Bio-Rad Laboratories), and probed 
with an anti-DGKζ antibody for DGKζ expression (71). To analyze Ras, 
Erk, Mek1/2, Jnk, and PLCγ1/2 activation, IgE-sensitized BMMCs were 
resuspended in Tyrode’s buff  er. Cells were left unstimulated or stimulated 
with DNP-HSA for diff  erent times or PMA (100 ng/ml) for 5 min. For 
IgE alone activation of Ras and Erk, cells were not sensitized, but rather 
were stimulated with 1 μg/ml IgE or PMA. Phosphorylation of these pro-
teins was determined by Western blot with antiphospho-specifi  c  anti-
bodies for Erk1/2, Mek1/2, Jnk, Akt, and PLCγ1 and PLCγ2 (Cell Signal 
Technology). Membranes were stripped and reprobed with antibodies to 
Erk, Mek1, Jnk, Akt, and actin for loading controls. Activated Ras in cell 
lysates was determined by GST-Raf-RBD “pull-down” assay as described 
previously (38).
PKC membrane localization. BMMCs were sensitized for 4 h with 
1 μg/ml IgE in IMDM-15 without cytokines and rested for 1 h at 37°C in 
Tyrode’s buff   er. Cells were stimulated with 50 ng/ml DNP-HSA or 
100 ng/ml PMA for 10 min, and membrane fractions were isolated as 
  described previously (72). Protein concentration in Triton soluble fraction 
was quantifi  ed using a bicinchonic acid assay (Pierce Chemical Co.) before 
PAGE analysis. Western blots were probed with antibodies to PKCδ 
(Cell Signal Technology), PKCβII (Santa Cruz Biotechnology, Inc.), and 
calnexin (Stressgen Bioreagents).
Detection of IL-6 production. Measurement of IL-6 production by 
BMMCs was performed as described with modifi  cations (13). BMMCs 
were rested overnight in IMDM-15 plus IL-3. For the unstimulated con-
dition, cells were resuspended in IMDM-10 at 2.5 × 105 cells/ml. 200 μl 
cells were seeded in each well of a 96-well plate in triplicate. For FcεRI 
stimulation, cells were washed and sensitized with 1 μg/ml anti-DNP 
IgE in IMDM-10 at 107 cells/ml for 4 h, pelleted, washed once with 
IMDM-10, and resuspended at 5 × 105 cells/ml in IMDM-10. 100 μl 
  aliquots of cells were placed into wells of a 96-well plate, followed by 
  addition of 100 μl of IMDM-10 with 2 μg/ml of anti-DNP-IgE, with 
60 ng/ml DNP-HSA, or with 40 ng/ml PMA and 200 ng/ml Io. Cells 
were incubated at 37°C with 5% CO2 for 24 h and IL-6 in supernatants 
was measured using a murine IL-6 ELISA kit (Pierce Chemical Co.). 
Data are normalized to PMA/Io control.
𝗃-hexosaminidase release assay. Hexosaminidase release assay was per-
formed as described previously with modifi  cation (13). BMMCs grown in 
IMDM-15 supplemented with IL-3 were stimulated with IgE at 37°C for 1 h 
to assess IgE-induced degranulation or were sensitized with 1 μg/ml IgE 
for 4 h and left unstimulated or stimulated with 10 ng/ml of DNP-HSA 
or PMA plus Io at 37°C for 1 h. β-Hexosaminidase activities in the medium 
and in whole cell lysates were determined using p-nitro-phenyl-N-acetyl-
β-D-glucosamide as the substrate.
Passive cutaneous anaphylaxis assay. The passive cutaneous anaphy-
laxis assay was performed according to published protocols (73). Mice 
were anesthetized by intraperitoneal injection of 300 μl of 2.5% 2,2,2-
  tribromoethanol in tert-amyl alcohol/PBS (1/40; Sigma-Aldrich), followed 
by subcutaneous injection of 25 ng IgE in 25 μl PBS in the right ear and 
25 μl PBS in the left ear. 24 h later, mice were anesthetized and 200 μl anti-
gen (100 μg DNP-HSA, 1% Evans blue in PBS) was injected intravenously 
via the retroorbital sinus. 30 min after the injection, mice were killed and 
both ears were removed. Ears were incubated in 200 μl formamide at 55°C 
for 48 h to extract the dye. Tissue debris was removed by centrifugation and 
the intensities of the dye were measured by absorption at 610 nm. The data 
are calculated as OD610 of the IgE-injected ear minus the OD610 of the PBS-
injected ear from the same mouse.
Calcium fl  ux. BMMCs were sensitized with 1 μg/mL IgE for 4 h; 
  re  suspended at 107 cells/ml in Tyrode’s buff  er containing 3 μg/ml Indo-1 
(Invitrogen) and 4 mM probencid; and incubated for 30 min at 37°C. Cells 
were washed twice with Tyrode’s buff  er and resuspended at 2 × 107 cells/ml. 
40 μl of cells was added into 460 μl of prewarmed Tyrode’s buff  er to mea-
sure Ca2+ responses by fl   ow cytometry (BD-LSR; Becton Dickinson). 
  After collection of the baseline ratio of FL5 to FL4, 10 μl of 5 μg/ml 
DNP-HSA was added to stimulate cells. Calcium fl  ux was assessed as the 
ratio of FL5 to FL4 fl  uorescence.
Online supplemental material. For measurement of DGK transcript 
levels, RNA was isolated from WT and DGKζ−/− BMMCs by TRIzol 
extraction (Invitrogen) and cDNA generated by reverse transcriptions 
(CLONTECH Laboratories, Inc.). Transcripts were quantifi  ed by SYBR 
green real-time PCR using the following primers: DGKα: 5′-G  A  T  G  C  A  G-
G  C  A  C  C  C  T  G  T  A  C  A  A  T  -3′, 5′-G  G  A  C  C  C  A  T  A  A  G  C  A  T  A  G  G  C  A  T  C  T  -3′; 
DGKδ: 5′-G  G  G  A  C  C  T  C  A  A  G  G  A  C  C  T  T  G  G  T  -3′, 5′-T  C  A  G  C  T  C  C  T  T  G  A-
T  C  C  C  A  C  A  A  A  ; and DGKι: 5′-T  T  C  C  C  C  A  G  G  G  C  A  C  T  C  T  C  A  -3′, 5′-C  A-
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a no reverse transcriptase control sample (unpublished data). Transcripts were 
normalized to GAPDH signal (5′-G  A  A  G  G  T  A  C  G  G  A  G  T  C  A  A  C  G  G  A  T    T    T  -3′, 
5′-G  A  A  T  T  T  G  A  C  C  A  T  G  G  G  T  G  G  A  A  T  -3′) using the ∆∆Ct method. For 
measurement of total cellular protein levels of PKCβII and PKCδ, WT and 
DGKζ−/− BMMCs were left unstimulated for 4 h in cytokine-free media 
with or without IgE (1 μg/ml). Cells were lysed in 1% NP-40 lysis buff  er 
with protease inhibitors, proteins were resolved by SDS-PAGE, and Western 
blots were probed with antibodies to PKCβII or PKCδ. Blots were stripped 
and reprobed for actin as a loading control. Online supplemental material is 
available at http://www.jem.org/cgi/content/full/jem.20052424/DC1.
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